首页 | 本学科首页   官方微博 | 高级检索  
检索        

急性心肌梗死患者血清hsCRP水平与急诊冠脉介入治疗后心衰的关系
引用本文:史卫国,牟晓雯,袁涛,王津文,周春.急性心肌梗死患者血清hsCRP水平与急诊冠脉介入治疗后心衰的关系[J].心血管康复医学杂志,2012,21(2):158-161.
作者姓名:史卫国  牟晓雯  袁涛  王津文  周春
作者单位:1. 青岛市第八人民医院心内科,山东青岛,266100
2. 青岛市第八人民医院特检科,山东青岛,266100
摘    要:目的:探讨急性心肌梗死(AMI)患者接受急诊冠状动脉介入治疗(PCI)术后心力衰竭与术前高敏C反应蛋白(hsCRP)水平之间的关系。方法:对于170例首次AMI患者根据入院hsCRP的水平分为G1组(hsCRP≤5.1mg/L,44例),G2组(5.2mg/L38.6mg/L,37例),比较各组心力衰竭发生率。采用Logistic逐步回归法分析急诊PCI术后心力衰竭发生的危险因素。结果:两年中34例(20%)发生心力衰竭。随着PCI术前hsCRP水平的升高,心力衰竭的发生率逐渐上升(G1组~G4组分别为:9.1%比16.0%比28.2%比29.7%,P均〈0.05);与同组PCI术后1周比较,术后1年时G3组、G4组的左室舒张末期容积指数(58.61±10.10)ml/m2比(61.84±9.92)ml/m2,(59.70±11.88)ml/m2比(66.46±10.52)ml/m2]、左室收缩末期容积指数(28.20±6.55)ml/m2比(31.06±7.14)ml/m2,(27.40±6.49)ml/m2比(31.62±8.03)ml/m2]明显增加,左室射血分数明显减低(52.56±7.58)%比(49.56±9.63)%,(53.19±8.12)%比(48.73±7.11)%],P〈0.05~0.01。Logistic逐步回归分析显示术前hsCRP水平是AMI患者发生心衰的预测因素(相对危险度为1.052,P=0.003)。结论:高敏C反应蛋白是急性心肌梗死患者PCI术后心力衰竭发生的预测因子之一。

关 键 词:C反应蛋白质  血管成形术  经腔  经皮冠状动脉  心肌梗塞

Relationship between serum level of hsCRP and heart failure after primary PCI in AMI patients
SHI Wei-guo , MU Xiao-wen , YUAN Tao , WANG Jin-wen , ZHOU Chun.Relationship between serum level of hsCRP and heart failure after primary PCI in AMI patients[J].Chinese Journal of Cardiovascular Rehabilitation Medicine,2012,21(2):158-161.
Authors:SHI Wei-guo  MU Xiao-wen  YUAN Tao  WANG Jin-wen  ZHOU Chun
Institution://Department of Cardiology,Eighth People’s Hospital of Qingdao City,Qingdao,Shandong,266100,China
Abstract:Objective: To investigate relationship between preoperative serum level of high sensitive C reactive protein(hsCRP) and chronic heart failure(CHF)after primary percutaneous coronary intervention(PCI) in patients with acute myocardial infarction(AMI).Methods:According to hsCRP level at admission,a total of 170 patients with first AMI onset were divided into group G1(hsCRP≤5.1 mg/L,n=44),group G2(5.2 mg/L38.6 mg/L,n=37).CHF incidence rate of each group was compared.Logistic gradual regression method was used to analyze risk factors for heart failure after primary PCI.Results:A total of 34(20%) cases occurred CHF within two years.As preoperative hsCRP level increased,CHF incidence rate gradually increased(from group G1 to G4 was 9.1% vs.16.0% vs.28.2% vs.29.7% respectively,P<0.05 all);Compared with one week after PCI,there were significant increase in left ventricular end-diastolic volume index (58.61±10.10) ml/m2 vs.(61.84±9.92) ml/m2,(59.70±11.88) ml/m2 vs.(66.46±10.52) ml/m2]and left ventricular end-systolic volume index (28.20±6.55) ml/m2 vs.(31.06±7.14) ml/m2,(27.40±6.49) ml/m2 vs.(31.62±8.03) ml/m2],and significant decrease in LVEF (52.56±7.58)% vs.(49.56±9.63)%;(53.19±8.12)% vs.(48.73±7.11)%]after PCI one year in group G3 and group G4,P<0.05~<0.01.Logistic gradual regression indecated that preoperative hsCRP level was a predictive factor for CHF in AMI patients(relative risk=1.052,P=0.003).Conclusion: hsCRP is one of predictive factors for CHF after PCI in AMI patients.
Keywords:C-reactive protein  Angioplasty  transluminal  percutaneous coronary  Myocardial infarction
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号